The Global Battle Against Antibiotic Resistance: A Silent Pandemic

Antibiotic resistance poses a deadly global threat, yet only a few pharmaceutical companies are conducting research into new antibiotics due to low profitability. The Access to Medicine Foundation is calling for more research into new antibiotics, as drug resistance is a major threat. The lack of new active substances is not limited to developing countries, as industrialized nations also struggle with the problem. The foundation emphasizes the need for responsibility and transparency in marketing and sales, as well as discouraging the overuse of conventional antibiotics. The development of antibiotic resistance is outpacing the availability of new antibiotics, highlighting the urgent need for increased research and distribution.